ARDS - Nursing Case Study

Pathophysiology

• Primary mechanism: Inflammatory response - ARDS begins with a widespread inflammatory response in the lungs, often triggered by trauma, infection, or other insults. This leads to increased permeability of the alveolar-capillary membrane, resulting in fluid leakage into the alveoli.

• Secondary mechanism: Surfactant dysfunction - The excess fluid in the alveoli dilutes and disrupts surfactant, a substance that reduces surface tension. This dysfunction causes alveolar collapse (atelectasis), reducing lung compliance and impairing gas exchange.

• Key complication: Impaired oxygenation - The accumulation of fluid and collapsed alveoli severely impair oxygen exchange, leading to hypoxemia. This can cause organ dysfunction and necessitates interventions such as mechanical ventilation to support respiratory function.

Patient Profile

Demographics:

52-year-old male, construction worker

History:

• Key past medical history: Hypertension, type 2 diabetes, and a history of smoking (20 pack-years)

• Current medications: Lisinopril, Metformin, and Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and worsening cough

• Key symptoms: Acute respiratory distress, fever, fatigue, and chest discomfort

• Vital signs: Temperature 38.3°C (100.9°F), heart rate 115 bpm, respiratory rate 28 breaths per minute, blood pressure 145/92 mmHg, oxygen saturation 88% on room air

Section 1

As the healthcare team monitors the 52-year-old male patient with ARDS, they observe a change in his status that requires immediate attention. Despite initial interventions, including supplemental oxygen therapy, his respiratory distress worsens. The patient's oxygen saturation drops to 82% even while on a non-rebreather mask at 15 L/min, indicating a significant impairment in gas exchange. His respiratory rate increases to 32 breaths per minute, and he appears increasingly anxious and diaphoretic. Auscultation of the lungs now reveals diffuse crackles bilaterally, consistent with fluid accumulation in the alveoli, and diminished breath sounds in the lower lobes, suggesting areas of atelectasis.

In response to these changes, the medical team orders a repeat arterial blood gas (ABG) analysis and a chest X-ray. The ABG results show a pH of 7.32, PaCO2 of 50 mmHg, and PaO2 of 55 mmHg, indicating respiratory acidosis with severe hypoxemia. The chest X-ray reveals bilateral infiltrates, a hallmark of ARDS, and further confirms the presence of widespread alveolar collapse. These findings prompt a discussion about the need for mechanical ventilation to support the patient's respiratory function and improve oxygenation.

As the patient is prepared for intubation, the team must consider the potential complications associated with mechanical ventilation, such as ventilator-associated pneumonia and barotrauma. They also need to evaluate the patient's fluid status and consider the use of conservative fluid management strategies to reduce pulmonary edema. This situation emphasizes the importance of continuous monitoring and reassessment, as well as the need for a collaborative approach to manage the complexities of ARDS effectively.

Section 2

As the healthcare team initiates mechanical ventilation, they set the ventilator to deliver a low tidal volume and employ a high positive end-expiratory pressure (PEEP) strategy to improve oxygenation and prevent further alveolar collapse. Initially, the patient's oxygen saturation improves to 93%, and his respiratory rate decreases to a more manageable 20 breaths per minute. However, over the next several hours, the patient begins to exhibit signs of hemodynamic instability. His blood pressure drops to 85/60 mmHg, and his heart rate increases to 110 beats per minute, raising concerns about potential complications associated with mechanical ventilation.

The team suspects the development of ventilator-induced lung injury, specifically barotrauma, as they note subcutaneous emphysema in the patient's neck and upper chest. A repeat chest X-ray is ordered and reveals the presence of a pneumothorax on the right side, contributing to the patient's respiratory distress and hypotension. Additionally, the echocardiogram shows signs of impaired cardiac output, likely exacerbated by the high PEEP settings. The healthcare team must now rapidly address the pneumothorax by placing a chest tube to re-expand the lung and adjust the ventilator settings to minimize further lung injury.

Concurrently, the patient's laboratory results return, showing a decrease in hemoglobin levels to 9 g/dL from an initial 13 g/dL, indicating possible blood loss or hemodilution. The team opts to reassess the patient's fluid status, considering the balance between adequate perfusion and the risk of exacerbating pulmonary edema. This complication emphasizes the delicate balance required in managing ARDS, necessitating continuous evaluation and adjustment of therapeutic strategies. The team's next steps involve closely monitoring the patient's response to the chest tube insertion and reassessing both his respiratory and hemodynamic status, ensuring that all interventions align with the overarching goal of stabilizing the patient while minimizing additional risks.

Section 3

As the healthcare team continues to monitor the patient's response to the interventions, they notice an initial improvement following the insertion of the chest tube. The patient's oxygen saturation rises to 95%, and his respiratory distress appears to diminish slightly. However, the hemodynamic instability persists, with blood pressure remaining low at 88/62 mmHg and a heart rate that has climbed to 115 beats per minute. These findings prompt a reassessment of the patient's fluid status and the potential need for vasopressor support. The team decides to administer a conservative fluid bolus of 250 mL of normal saline, carefully balancing the risk of worsening pulmonary edema against the need to improve perfusion.

Shortly after these interventions, the patient's laboratory results reveal a lactate level of 3.5 mmol/L, indicating a degree of tissue hypoperfusion and raising concerns about systemic hypoperfusion. The team recognizes that the high PEEP settings, while necessary for improving oxygenation, may be contributing to decreased venous return and subsequent cardiovascular compromise. In response, the ventilator settings are adjusted to slightly lower the PEEP while ensuring that tidal volumes remain within protective lung strategy parameters to prevent further lung injury.

Simultaneously, repeat arterial blood gas analysis shows a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 68 mmHg, reflecting a mixed respiratory and metabolic acidosis. The team initiates a low-dose norepinephrine infusion to support blood pressure and enhance organ perfusion, while continuing to monitor both respiratory and hemodynamic parameters closely. This multifaceted approach underscores the complexity of balancing respiratory and cardiovascular demands in the management of ARDS, highlighting the importance of ongoing assessment and adjustment of therapeutic strategies to optimize patient outcomes.

Section 4

As the team continues to monitor the patient, they observe a change in his status that prompts further evaluation. Despite the administration of norepinephrine and adjustments to the ventilator settings, the patient's blood pressure remains unstable, fluctuating between 85/60 mmHg and 92/64 mmHg. Heart rate remains elevated at 118 beats per minute, and capillary refill time is notably delayed. The patient's urine output has decreased to less than 0.5 mL/kg/hr over the past two hours, suggesting potential renal hypoperfusion. These findings raise alarms about the adequacy of current interventions and the possible development of acute kidney injury (AKI) secondary to sustained low cardiac output and systemic hypoperfusion.

To assess the situation further, a central venous catheter is placed to monitor central venous pressure (CVP), which reads at 4 mmHg, indicating low preload and supporting the suspicion of inadequate intravascular volume. Concurrently, a repeat lactate level shows a slight increase to 3.8 mmol/L, suggesting ongoing tissue hypoxia. The team discusses the risk-benefit ratio of administering additional fluids, taking into account the potential for exacerbating pulmonary edema versus the need to improve renal perfusion and systemic circulation.

In response to these developments, the decision is made to carefully administer another 250 mL fluid bolus of balanced crystalloid solution, while closely monitoring the patient's respiratory status, urine output, and hemodynamic changes. Additionally, the norepinephrine infusion is titrated upward to support systemic vascular resistance and enhance perfusion. This integrated approach reflects the delicate balance required to manage complex cases of ARDS with concurrent cardiovascular and renal challenges, emphasizing the need for vigilant reassessment and dynamic adjustment of therapeutic strategies. The team remains alert to the possibility of further complications and is prepared to intervene promptly as needed.

Section 5

As the team implements the adjusted treatment plan, they closely monitor the patient's response to the fluid bolus and increased norepinephrine infusion. Over the next hour, there is a modest improvement in hemodynamics; the blood pressure stabilizes slightly at 95/65 mmHg, and the heart rate decreases to 110 beats per minute. However, despite these gains, the patient's urine output remains low, registering at only 0.3 mL/kg/hr, which continues to indicate inadequate renal perfusion. Additionally, the patient's central venous pressure has increased to 6 mmHg, suggesting a slight improvement in preload, yet there is still concern about overall fluid balance given the risk of worsening pulmonary edema.

In conjunction with these findings, a new set of arterial blood gases reveals a persistent metabolic acidosis with a pH of 7.28, PaCO2 of 42 mmHg, HCO3- of 16 mEq/L, and a lactate level that remains elevated at 3.9 mmol/L. These results underline ongoing tissue hypoxia and inadequate perfusion, despite the current interventions. The team recognizes the need to further explore potential underlying causes of the patient's deteriorating condition, considering factors such as cardiac function and potential sepsis-related complications, which may be contributing to the persistent hemodynamic instability and renal impairment.

To address these concerns, an echocardiogram is ordered to evaluate cardiac function more comprehensively, while additional blood cultures are drawn to rule out any infectious processes that could be complicating the clinical picture. This stepwise approach is crucial as the team strives to fine-tune their management strategies, ensuring they balance the need to optimize perfusion while minimizing the risk of exacerbating respiratory distress. The evolving situation demands continued vigilance and adaptability, with an understanding that the patient's condition may require further escalation of care depending on forthcoming diagnostic insights.